The Pattern of Progression to First-Line Treatment with Dabrafenib and Trametinib in Patients with Unresectable or Metastatic, BRAF-Mutated, Cutaneous Melanoma: Results of the Observational T-WIN Study

Michele Del Vecchio, Paola Queirolo, Pietro Quaglino et al.|Cancers|2023

Cited by 2